Posted on May 6, 2024 by Shloka BadkarStocks to watch: Kotak Mahindra Bank, Titan, Britannia, CDSL, IDBI Bank and more Kotak Mahindra Bank: Net Interest Income of ₹6,909 crore, higher than poll estimate of ₹6,670.2 crore. Net profit of ₹4,133.3 crore also higher than the CNBC-TV18 poll of ₹3,376.9 crore. AIF provisions worth ₹157 crore released during the quarter. Write-offs of ₹1,455 crore in retail, unsecured book aids Gross NPA. Favourable tax credit of ₹200 crore during the quarter. Gross NPA at 1.39% from 1.73% in December, while Net NPA remains flat at 0.34%. Net Interest Margin expands sequentially compared to expectations of a fall. Britannia: Net profit of ₹536.6 crore, compared to a CNBC-TV18 poll of ₹541 crore. Revenue of ₹4,069.4 crore in-line with expectations. EBITDA also meets expectations at ₹785.5 crore, while EBITDA margin at 19.4%, fell 50 basis points year-on-year but was 20 basis points higher than estimates. Titan: Net profit of ₹786 crore, below the CNBC-TV18 poll of ₹830 crore. Revenue of ₹11,257 crore, meets estimates of ₹11,300 crore. EBITDA of ₹1,109 crore, below estimates of ₹1,250 crore. EBITDA margin also misses expectations of 11.1%, coming in at 9.9% for the quarter. Jewellery business margin at 12.3%, watches business margin at 10.2%, eyewear margin at 11.7%. While jewellery and watches margin meets estimates, eyewear margins surpassed expectations. Also announces dividend of ₹11 per share. Avenue Supermarts: Net profit up 22.5% to ₹563.3 crore. Revenue up 20.1% to ₹12,726.6 crore. EBITDA up 22.3% to ₹944 crore, while EBITDA margin expands by 10 basis points to 7.4% from 7.3%. M&M Financial Services: Net Interest Income up 15.5% to ₹1,918.9 crore. Net profit down 9.5% to ₹619 crore. Provisions at ₹341.5 crore from ₹328.4 crore last quarter. Gross NPA at 3.4% from 3.97% in December. Gross NPA of housing subsidiary at 9% from 11.55% in December. Net recoverable balance post fraud at ₹135.9 crore. Provisions have been made in this regard. Zen Technologies: Won orders worth ₹1,358 crore during the financial year. Order book as of March 31, 2024 at over ₹1,400 crore. Poised to sustain growth in FY25, aiming to surpass ₹900 crore in sales. Aim to launch a range of innovative products in the coming days and months for both Indian armed forces and international clients. Tata Technologies: Constant currency revenue growth of 0.3% sequentially. Services revenue down 1% sequentially. Anticipated ramp down within VinFast led to drop in services revenue. Ex-Vinfast, Services revenue grew by 10.4% sequentially and 31.7% year-on-year. Expect to see further run-off in VinFast in Q1. Net profit down 27.4% due to higher taxes and lower other income. Kansai Nerolac Paints: Good performance from the decorative segment. Revenue up 2.1% to ₹1,769 crore. EBITDA margin expands by 40 basis points to 10.1%. Decorative paints saw double-digit volume growth. Industrial coatings moderated over the previous quarter. Forecast of a good monsoon should augur well for the paint industry. Total resins capacity at two plants to increase from 907 MT per month to 1,757 MT per month. CDSL: Total income up 86% from last year to ₹267 crore. Net profit up 63% year-on-year to ₹129 crorre. Board recommended final dividend of ₹19 per share and a special dividend of ₹3 per share. 11.56 crore demat accounts in March 2024.] IDBI Bank: Net Interest Income up 12.4% to ₹3,687.9 crore, net profit up 43.7% from last year to ₹1,628.5 crore. Provisions down 88.4% from last year to ₹113.8 crore. Gross NPA at 4.53% from 4.69%, while Net NPA at 0.34%. Slippages triple to ₹1,852 crore from ₹614 crore last year, while write-offs rise to ₹433 crore from ₹316 crore last year. MRPL: Net profit down 40.5% to ₹1,138.5 crore. Revenue flat at ₹25,328.7 crore. EBITDA down 33.3% at ₹2,329.7 crore. EBITDA margin down 460 basis points to 9.2%. GR at $11.35 per barrel from $15.12 per barrel. Aurobindo Pharma: USFDA issues seven observations for Unit-II of the formulations manufacturing facility in Bhiwadi in Rajasthan. The facility was inspected between April 25 – May 3, 2024. The company said that the observations are procedural in nature. Adani Ports: Group expresses interest to acquire and develop Bataan Port in the Philippines. Ujjivan Small Finance Bank: Sanjeev Nautiyal appointed as MD & CEO for a period of three years starting July 1. He was earlier Deputy MD Financial Inclusion and Micro Markets of SBI and MD & CEO of SBI Life Insurance. Zydus Lifesciences: US arm Sentynl Therapeutics acquires worldwide proprietary rights to Zokinvy at a net base price of $45 million from US-based Eiger Biopharmaeuticals. Zokinvy is approved for the treatment of a collection of ultra-rare, fatal, genetic premature ageing diseases.